Skip to main content
. Author manuscript; available in PMC: 2008 Sep 4.
Published in final edited form as: Vaccine. 2007 Jul 19;25(36):6598–6603. doi: 10.1016/j.vaccine.2007.06.057

Figure 1.

Figure 1

ELISA antibody titers to MSP1-19 of mice, IL-6 KO and WT, immunized with P30P2MSP1-19 in different adjuvant formulations. Mouse sera were obtained at 21 days after tertiary immunizations. Symbols: Black bars: WT mice; Grey bars: IL-6 KO mice. Significant differences (Student t test) between WT and IL-6 KO mice of an adjuvant group are indicated by asterisks.